Floatz logo

FLUOROURACILUM

Gastro-enteropancreatic Neuroendocrine Tumor

Hospices Civils de LyonSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Gastro-enteropancreatic Neuroendocrine Tumor cohort.

Asset / SponsorPhaseRating
EUDEMINE INJECTION
University of Maryland, Baltimore
Phase 4BB
Irinotecan
Roswell Park Cancer Institute
Phase 2BB
Regorafenib
Translational Research in Oncology
Phase 2B
Pasireotide
University of Maryland, Baltimore
Phase 4B
FOSLINANIB
TaiRx, Inc.
Phase 2CCC
Eloxatin
Hospices Civils de Lyon
Phase 2CCC
Calcium folinate pentahydrate
Roswell Park Cancer Institute
Phase 2CCC
Avelumab
Institut Bergonié
Phase 1/2CC

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →